Mix and match - A comprehensive pipeline for matched patient-derived PDX and PD3D® modelsfor cancer research and preclinical drug development

被引：1
|
作者：
Loskutov, Jurgen
Oswald, Eva
Reinhard, Christoph J.
Schueler, Julia
Regenbrecht, Christian R.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Novel patient-derived 3D (PD3D) cell models and matched patient-derived xenografts (PDX) from peritoneal metastasis of colorectal cancer for drug testing and biomarker analysis
    Regenbrecht, Christian R. A.
    Gambara, Guido
    Pachmayr, Eva
    Silvestri, Alessandra
    Dahlmann, Mathias
    Brzezicha, Bernadette
    Buettner, Britta
    Rau, Beate
    Keilholz, Ulrich
    Stein, Urike
    Walther, Wolfgang
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Development of patient-derived xenograft (PDX) models for pancreatic carcinoma as a preclinical platform for drug development
    Ricono, Jill
    Thatte, Jayant
    Scott, Colleen
    Broudy, Thomas B.
    CANCER RESEARCH, 2016, 76
  • [3] Development of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Mullins, Chelsea
    Ricono, Jill
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75
  • [4] Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
    Xu, Xiaoxi
    Shang, Limei
    Wang, Philip
    Zhou, Jun
    Ouyang, Xuesong
    Zheng, Meiling
    Mao, Binchen
    Zhang, Likun
    Chen, Bonnie
    Wang, Jingjing
    Chen, Jing
    Qian, Wubin
    Guo, Sheng
    Huang, Yujun
    Li, Qi-Xiang
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (171):
  • [5] Establishment of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Carlson, Patrick
    Ricono, Jill
    Mullins, Chelsea
    Broudy, Thomas
    Mirsaidi, Cyrus
    Nair, Praveen
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Patient-derived organoids as an epithelial model for preclinical IBD research and drug development
    Frias, J.
    Derksen, M.
    Verissimo, C. S.
    van Dooremalen, W. T. M.
    Oldenburg, B.
    Vries, R. G. J.
    Boj, S. F.
    Pourfarzad, F.
    Pott, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I182 - I182
  • [7] Modeling patient-derived lung cancer in mice: Preclinical tool for drug development
    Gokhale, Prafulla C.
    Palakurthi, Sangeetha
    Xu, Man
    Calles, Antonio
    Shah, Shruti D.
    O'Connell, Allison
    Messineo, Melissa
    Kuang, Yanan
    Yanagita, Masahiko
    Ali, Mosab
    Tran, Cam Anh
    Choi, Jihyun
    Ogino, Atsuko
    Butaney, Mohit
    Redig, Amanda J.
    Paweletz, Cloud
    Kirschmeier, Paul T.
    Jaenne, Pasi A.
    CANCER RESEARCH, 2015, 75
  • [8] Development of breast cancer patient-derived xenograft models as preclinical tool for drug discovery
    Rymer, Isha C.
    Wang, Jinwei
    Zhu, Zhou
    Schwab, Richard
    Wallace, Anne M.
    Blair, Sarah L.
    Greenberg, Norman
    Yang, Wei J.
    CANCER RESEARCH, 2011, 71
  • [9] A comprehensive biobank of PD3D® models and technology platform for cancer research and therapy response prediction
    Wedeken, L.
    Loskutov, J.
    Ruhe, L.
    Schueler, J.
    Uhlig, K.
    Kaul, D.
    Regenbrecht, C. R.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S109 - S109
  • [10] New patient-derived head and neck cancer xenograft (PDX) panel for drug development, immuno-oncology and translational research
    Brzezicha, Bernadette
    Conrad, Theresia
    Stecklum, Maria
    Becker, Michael
    Klinghammer, Konrad
    Hoffmann, Jens
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
12345